Evidence map›Paper›PMID 29088304›Full record

ArticlePloS one2017

Wound healing properties of Copaifera paupera in diabetic mice.

Jorge Luis Amorim, Janaína de Barros Figueiredo, Ana Claudia Fernandes Amaral, Eliane Gouvêa de Oliveira Barros, Célia Palmero, Maria Athana MPalantinos, Aline de Souza Ramos, José Luiz Pinto Ferreira, Jefferson Rocha de Andrade Silva, Claudia Farias Benjamim and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Skin Tear Treatment withPharmaceuticals (Basel, Switzerland) · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Transcriptome Analysis of Oleoresin-Producing TreeFrontiers in plant science · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jorge Luis AmorimUniversidade Federal do Rio de Janeiro, Instituto de Ciências Biomédicas, Laboratório de Farmacologia da Dor e da Inflamação, Rio de Janeiro, Brasil.
Janaína de Barros FigueiredoUniversidade Federal do Rio de Janeiro, Instituto de Biofísica Carlos Chagas Filho, Rio de Janeiro, Brasil.
Ana Claudia Fernandes AmaralFIOCRUZ, Farmanguinhos, Rio de Janeiro, Brasil.
Eliane Gouvêa de Oliveira BarrosUniversidade Federal do Rio de Janeiro, Instituto de Ciências Biomédicas, Laboratório de Interações Celulares, Rio de Janeiro, Brasil.
Célia PalmeroUniversidade Federal do Rio de Janeiro, Instituto de Ciências Biomédicas, Laboratório de Interações Celulares, Rio de Janeiro, Brasil.
Maria Athana MPalantinosFIOCRUZ, Farmanguinhos, Rio de Janeiro, Brasil.
Aline de Souza RamosFIOCRUZ, Farmanguinhos, Rio de Janeiro, Brasil.
José Luiz Pinto FerreiraFIOCRUZ, Farmanguinhos, Rio de Janeiro, Brasil.
Jefferson Rocha de Andrade SilvaFIOCRUZ, Farmanguinhos, Rio de Janeiro, Brasil.
Claudia Farias BenjamimUniversidade Federal do Rio de Janeiro, Instituto de Biofísica Carlos Chagas Filho, Rio de Janeiro, Brasil.
Silvia Luciane BassoUniversidade Federal do Amazonas, Departamento de Química, Laboratório de Cromatografia, Manaus, Brasil.
Luiz Eurico NasciuttiUniversidade Federal do Rio de Janeiro, Instituto de Ciências Biomédicas, Laboratório de Interações Celulares, Rio de Janeiro, Brasil.
Patricia Dias FernandesUniversidade Federal do Rio de Janeiro, Instituto de Ciências Biomédicas, Laboratório de Farmacologia da Dor e da Inflamação, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0001-6870-6745
Universidade Federal do Rio de Janeiro · BRFundação Oswaldo Cruz · BRUniversidade Federal do Amazonas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copaifera oleoresin is one of the most used natural products in popular medicine all over the world. Among other effects (i.e., anti-inflammatory, antinociceptive, microbicidal) one of the most well-known is its wound healing capacity. However, the mechanism by which the oleoresin presents its effect is still not clear. In this study, our aim was to evaluate the wound healing capacity of oleoresin obtained from Copaifera paupera, its mechanism of action and identify its major components. For these purposes, diabetic Swiss Webster mice were topically treated with oleoresin (100, 150 or 200 mg/kg) for 14 consecutive days after an excision was performed in the back of the mice. Cytokines, wound retraction and histological evaluation were conducted at 3, 7 and 10 days (for cytokines); 0, 3, 7, 10 and 14 days (for wound retraction); and 7 and 14 days (for histological evaluation). Our data indicate that oleoresin significantly reduced production of MCP-1 and TNF-α at days 7 and 10 post-excision and increased IL-10 production at both days. All treatments demonstrated an effect similar or higher to that in collagenase-treated mice. Histological evaluations demonstrated that higher dose treatment resulted in better resolution and closure of the wound and higher levels of collagen deposition and indexes of re-epithelialization even when compared with the collagenase-treated group. The treatment with oleoresin from Copaifera paupera demonstrated that it is even better than an ointment routinely used for improvement of wound healing, suggesting this oleoresin as an option for use in diabetic patients.

Indexed as

AnimalsChemokine CCL2FabaceaeGas Chromatography-Mass SpectrometryMaleMicePlant ExtractsTumor Necrosis Factor-alphaWound HealingCcl2 protein, mouseChemokine CCL2Plant ExtractsTumor Necrosis Factor-alpha

Identifiers

PMID29088304
PMCPMC5663518
OpenAlexW2767004508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.